The results indicated that ethyl ferulate treatment reduced patient-derived esophageal xenograft tumor growth by inhibiting the mTOR/AKT/p70S6K signaling pathway (Figures 6A, B, E, F). This evidence concerns the gene RPS6KB1 and neoplasm.